Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuro-cognitive changes in treatment-naïve HIV-1 patients starting two antiretroviral regimens
2007-002405-47Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nevirapine, atazanavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in simple reaction time. Started Jun 2007; status: completed.
02
Drugs
nevirapineatazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-002405-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002405-47.